Literature DB >> 3119023

Near fatal drug interactions with methotrexate given for psoriasis.

H W Ng1, A W Macfarlane, R M Graham, J L Verbov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3119023      PMCID： PMC1247775          DOI： 10.1136/bmj.295.6601.752

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Impact of methotrexate therapy on the folate status of psoriatic patients.

Authors:  J Hendel; A Nyfors
Journal:  Clin Exp Dermatol       Date:  1985-01       Impact factor: 3.470

2.  Megaloblastic anaemia in psoriatic patients treated with methotrexate.

Authors:  H J Dodd; J D Kirby; D D Munro
Journal:  Br J Dermatol       Date:  1985-05       Impact factor: 9.302

Review 3.  Cytotoxic agents for use in dermatology. I.

Authors:  C J McDonald
Journal:  J Am Acad Dermatol       Date:  1985-05       Impact factor: 11.527

4.  Two patterns of skin ulceration induced by methotrexate in patients with psoriasis.

Authors:  C M Lawrence; M G Dahl
Journal:  J Am Acad Dermatol       Date:  1984-12       Impact factor: 11.527

5.  Methotrexate toxicity precipitated by azapropazone.

Authors:  H M Daly; G L Scott; J Boyle; C J Roberts
Journal:  Br J Dermatol       Date:  1986-06       Impact factor: 9.302
  5 in total
  10 in total

1.  Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.

Authors:  Marsha L Voll; Kim D Yap; Wim E Terpstra; Mirjam Crul
Journal:  Pharm World Sci       Date:  2010-07-20

Review 2.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.

Authors:  Navtej Sathi; Julie Dawson
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

4.  Methotrexate induced skin necrosis: a drug interaction with amiodarone?

Authors:  N J Reynolds; S K Jones; J Crossley; R R Harman
Journal:  BMJ       Date:  1989-10-14

Review 5.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

6.  Severe renal toxicity due to intermediate-dose methotrexate.

Authors:  A N Stark; G Jackson; P J Carey; S Arfeen; S J Proctor
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 7.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

8.  Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.

Authors:  Oh Chan Kwon; Jung Sun Lee; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo; Seokchan Hong
Journal:  Clin Rheumatol       Date:  2018-01-30       Impact factor: 2.980

9.  A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole.

Authors:  Mohsin Hamid; Bilal Lashari; Irfan Ahsan; Ida Micaily; Usman Sarwar; Joseph Crocetti
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12

Review 10.  Clinically important drug interactions with disease-modifying antirheumatic drugs.

Authors:  C J Haagsma
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 4.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.